Neville D. Yeomans

University of Melbourne — Australia

Medicine · Health Sciences

43h-index8.0kcitations230works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Helicobacter pylori-related gastroenterology studies(111), Inflammatory mediators and NSAID effects(70), Gastroesophageal reflux and treatments(43), Antiplatelet Therapy and Cardiovascular Diseases(19), Drug-Induced Adverse Reactions(17)

Publications230 total

Sarcoidal reaction following <scp>COVID</scp>‐19 infection
Internal Medicine Journal·2024
Editorial: risk of gastric and duodenal ulcers among new users of low‐dose aspirin
Alimentary Pharmacology & Therapeutics·2022· 1 cited
International medical graduates ( <scp>IMGs</scp> ) in cul‐de‐sacs: “lost in the labyrinth” revisited?
The Medical Journal of Australia·2022· 4 cited
Demographics and distribution of australia's medical immigrant workforce
Journal of Migration and Health·2022· 13 citedOpen Access
A short history of time (with apologies to Stephen Hawking)
Academia Letters·2021· 1 cited
Demographics and performance of candidates in the examinations of the Australian Medical Council, 1978–2019
The Medical Journal of Australia·2020· 5 cited
A Dangerous Migration: Early Mortality in Immigrant Doctors in Colonial Victoria
Health and History·2020· 2 cited
Letter: mechanistic target of rapamycin inhibitors—do they impact on recurrence of hepatocellular carcinoma after liver transplantation? Authors' reply
Alimentary Pharmacology & Therapeutics·2019Open Access
Systematic review with meta‐analysis: sirolimus‐ or everolimus‐based immunosuppression following liver transplantation for hepatocellular carcinoma
Alimentary Pharmacology & Therapeutics·2019· 97 cited
Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis
Inflammatory Bowel Diseases·2019· 91 citedOpen Access
Letter: the effect of sirolimus on recurrence and survival in liver transplant recipients with hepatocellular carcinoma
Alimentary Pharmacology & Therapeutics·2018· 3 citedOpen Access
Sirolimus in Liver Transplant Recipients With Hepatocellular Carcinoma
Journal of Investigative Surgery·2018Open Access
Helicobacter pylori and low‐dose aspirin ulcer risk: A meta‐analysis
Journal of Gastroenterology and Hepatology·2018· 30 cited
Editorial: gastrointestinal safety of <scp>COX</scp>‐2 selective and nonselective <scp>NSAID</scp>s—the impact of the <scp>PRECISION</scp> trial. Authors’ reply
Alimentary Pharmacology & Therapeutics·2018Open Access
Mo1888 - Infliximab Salvage Therapy in Acute Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis
Gastroenterology·2018
Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the <scp>PRECISION</scp> trial
Alimentary Pharmacology & Therapeutics·2018· 51 citedOpen Access
The potential benefits of aspirin for primary cardiovascular prevention in rheumatoid arthritis: a secondary analysis of the PRECISION Trial
Lara D. Veeken·2018· 6 citedOpen Access
Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or Ibuprofen
Journal of the American College of Cardiology·2018· 44 citedOpen Access
Acute Pancreatitis With Long-Term Celecoxib VS. Ibuprofen or Naproxen: Data From the PRECISION Trial
The American Journal of Gastroenterology·2018· 2 cited
DOSE ESCALATION AND THE SAFETY OF CELECOXIB, IBUPROFEN, AND NAPROXEN: ANALYSIS OF THE PRECISION TRIAL
Journal of the American College of Cardiology·2018
page 1 of 12Next →

Frequent Co-authors

Steven E. Nissen(7), Daniel H. Solomon(7), Thomas F. Lüscher(7), M. Elaine Husni(7), Jeffrey Borer(7), L Wiśniewski(7), A. Michael Lincoff(7), Christopher J. Hawkey(6), Peter Libby(6), David Y. Graham(6), Venu Menon(5), A J Swannell(4), J. Næsdal(4), L Szczepański(3), Frank Ruschitzka(3), Weihang Bao(3), I Rácz(3), Nicholas J. Talley(3), Francis K.L. Chan(3), C J Hawkey(3)